Portage Biotech Inc (PRTG NASDAQ) stock market data APIs
$5.7245
0.03(0.5%)
as of September 17, 2025
Try our APIs with
free plan!
Portage Biotech Inc Financial Data Overview
Price chart is built with
Anychart
Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-3, a polylactide-co-glycolide, which is in phase 1 to treat NY-ESO-1 positive tumors; PORT-6, a highly selective A2A receptor antagonist, which is in phase 1a for the treatment of solid tumors; PORT-8, a dual inhibitor of adenosine receptors 2A and 2B, which is in preclinical trial to treat solid tumors; PORT-9, an A2B antagonist, which is in pre-clinical stage program to treat colorectal and gastrointestinal cancers; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; PORT-5, a VLP-STING to treat of solid tumors and is in preclinical trials; and PORT-7, a potent and selective antagonist of the adenosine A2B receptor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
Prev. Close
5.7245
Open
5.7587
High
5.8591
Low
5.4403
52 wk Range
2.95-15.8181
Market Cap
15 517 K
Shares Outstanding
2 279 K
EPS
-2.88
Beta
0.637
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Portage Biotech Inc data using free add-ons & libraries
Get Portage Biotech Inc Fundamental Data
Portage Biotech Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -7 383 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-15
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Portage Biotech Inc News
New
These stocks are moving in today's after hours session
As the regular session of the US market concludes on Thursday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. [postmarket] T...
'Biggest Opportunity for Mass Adoption': TON Treasury Loads Up on Telegram-Linked Coin
Biotech firm Portage Biotech is the latest publicly traded firm to shift its focus to a digital asset treasury, securing around $100 million to build a treasury centered on Toncoin (TON)—the asset l...
AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem
AlphaTON Capital Unlocks Public Market Access to Toncoin (TON) and Telegram’s Billion-User EcosystemBrittany Kaiser, pioneer in data protection, digital assets, and the public equity markets appoint...
AlphaTon Capital Shares Surge on TON Treasury Announcement
AlphaTON Capital, a Nasdaq-listed company newly rebranded from Portage Biotch (PRTG), said it will purchase about $100 million worth of toncoin (TON) to build a digital asset treasury firm offering ex...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
